Results 121 to 130 of about 834,780 (246)

Modeling the Role of Big Data Analytics Capabilities in Impacting Corporate Environmental Performance: A Serial Mediation Analysis

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT Big data analytical capabilities (BDAC) have emerged as a significant strategic tool for enhancing environmental performance in today's ever‐growing green and digital economy. However, the serial process through which BDAC influences environmental performance remains understudied, particularly in multinational corporations (MNCs).
Leul Girma Haylemariam   +2 more
wiley   +1 more source

Pareto in Prison

open access: yesBehavioral Sciences &the Law, EarlyView.
ABSTRACT The Pareto principle is based on the concept that roughly 80% of outcomes are generated by 20% of inputs, efforts, or contributors within a group. Using a national sample of U.S. prison inmates, we examined various percentile rankings of self‐reported institutional misconduct to determine how much disorder is created behind bars by the most ...
Mark A. Morgan   +3 more
wiley   +1 more source

Minimizing batch‐to‐batch variability of a live virus vaccine by process analytical technologies

open access: yesBiotechnology Progress, EarlyView.
Abstract For bioprocesses producing live virus, such as enterovirus Coxsackievirus A21, viral titer (infectivity basis) decay rates can exceed 30% within a day. Consequently, harvest timing is paramount. To optimize titer at harvest, a continuous viral product titer model was generated to elucidate kinetics.
Katherine Forrester   +4 more
wiley   +1 more source

Linking Criminal Justice-Involved Individuals to HIV Preexposure Prophylaxis: A Qualitative Analysis of Multiple Stakeholder Perspectives. [PDF]

open access: yesJ Int Assoc Provid AIDS Care
Lee J   +7 more
europepmc   +1 more source

An open‐label, single‐arm, multicenter, phase II trial of bireociclib as monotherapy for heavily pretreated HR‐positive, HER2‐negative advanced breast cancer patients: BRIGHT‐1 trial

open access: yesCancer Communications, EarlyView.
Abstract Background Bireociclib (XZP‐3287) is a novel selective cyclin‐dependent kinase 4 and 6 (CDK4/6) inhibitor, with a favorable safety profile demonstrated in preclinical and phase I studies. BRIGHT‐1 aimed to further explore the efficacy and safety of bireociclib monotherapy in patients with locally advanced, recurrent or metastatic, hormone ...
Jiayu Wang   +18 more
wiley   +1 more source

The Role of the Primary Care Transformation Lead: A Qualitative Case Study. [PDF]

open access: yesJ Prim Care Community Health
Joshi A   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy